Efficacy of Cabozantinib in Previously Treated RCC Is Consistent Irrespective of Prior Therapy
May 30, 2020 09:33pm
By Audrey Sternberg
Highlighting Key Trials in Kidney Cancer
Jun 01, 2019
Toni Choueiri, MD, director, Lank Center for Genitourinary Oncology, director, Kidney Cancer Center, senior physician, at Dana-Farber Cancer Institute, and Jerome and Nancy Kohlberg Chair and professor of medicine, at Harvard Medical School, highlights key trials in kidney cancer presented at the 2019 ASCO Annual Meeting.
